Olsson I, Persson A M, Strömberg K
Biochem J. 1984 Nov 1;223(3):911-20. doi: 10.1042/bj2230911.
The processing and intracellular transport of myeloperoxidase were studied in the human promyelocytic leukaemia cell line HL-60 and in normal marrow cells labelled with [35S]methionine or [14C]leucine. Myeloperoxidase was precipitated with antimyeloperoxidase serum; the immunoprecipitates were subjected to sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and radiolabelled myeloperoxidase visualized by fluorography. During a 1 h pulse, myeloperoxidase was labelled in a chain of apparent Mr 90 000. With a subsequent chase, the Mr 90 000 polypeptide disappeared and was replaced by chains of Mr 62 000 and 12 400 corresponding roughly to the size of neutrophil myeloperoxidase subunits. The identification of the radioactive polypeptides as different forms of myeloperoxidase was established also by the similarity in patterns generated by partial proteolysis with V8 proteinase from Staphylococcus aureus. Processing of myeloperoxidase in HL-60 was slow; mature polypeptides were significantly increased only after 6 h. Another myeloperoxidase chain of apparent Mr 82 000 was an intermediate precursor or degradation form. Pulse-chase experiments in combination with sucrose-density-gradient separations of homogenates showed that the Mr 90 000 precursor was located in light density organelles only and not in granule fractions, whereas the Mr 82 000 precursor was located only in intermediate density organelles, suggesting that the latter is a product of the former. Processed mature myeloperoxidase was concentrated in the granule fraction, but some occurred in lower density organelles, which may indicate processing during intracellular transport. Only the Mr 90 000 polypeptide was secreted into the culture medium; this was also the only form found in the cytosol fraction.
在人早幼粒细胞白血病细胞系HL-60以及用[35S]甲硫氨酸或[14C]亮氨酸标记的正常骨髓细胞中,研究了髓过氧化物酶的加工过程和细胞内运输。用抗髓过氧化物酶血清沉淀髓过氧化物酶;对免疫沉淀物进行十二烷基硫酸钠/聚丙烯酰胺凝胶电泳,并通过荧光自显影法观察放射性标记的髓过氧化物酶。在1小时的脉冲标记期间,髓过氧化物酶在一条表观分子量为90000的条带中被标记。随后进行追踪实验,90000分子量的多肽消失,取而代之的是分子量约为62000和12400的条带,大致对应于中性粒细胞髓过氧化物酶亚基的大小。通过用金黄色葡萄球菌V8蛋白酶进行部分蛋白水解产生的相似模式,也确定了放射性多肽为不同形式的髓过氧化物酶。HL-60中髓过氧化物酶的加工过程缓慢;仅在6小时后成熟多肽才显著增加。另一条表观分子量为82000的髓过氧化物酶条带是中间前体或降解形式。脉冲追踪实验结合匀浆的蔗糖密度梯度分离表明,90000分子量的前体仅位于低密度细胞器中,而不在颗粒组分中,而82000分子量的前体仅位于中等密度细胞器中,这表明后者是前者的产物。加工后的成熟髓过氧化物酶集中在颗粒组分中,但也有一些存在于较低密度的细胞器中,这可能表明在细胞内运输过程中发生了加工。只有90000分子量的多肽分泌到培养基中;这也是在胞质溶胶组分中发现的唯一形式。